Acadian Asset Management LLC Decreases Stock Holdings in Alignment Healthcare, Inc. $ALHC

Acadian Asset Management LLC reduced its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 12.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 329,426 shares of the company’s stock after selling 46,523 shares during the period. Acadian Asset Management LLC owned 0.17% of Alignment Healthcare worth $4,608,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. MCF Advisors LLC boosted its stake in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Alignment Healthcare during the 1st quarter worth $42,000. Signaturefd LLC raised its holdings in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after acquiring an additional 2,215 shares during the period. Regal Partners Ltd acquired a new position in shares of Alignment Healthcare during the 1st quarter valued at about $194,000. Finally, CWM LLC grew its holdings in shares of Alignment Healthcare by 137.6% in the first quarter. CWM LLC now owns 10,553 shares of the company’s stock valued at $196,000 after purchasing an additional 6,112 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. UBS Group raised their price target on shares of Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, October 31st. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective for the company in a research report on Monday, August 25th. Finally, JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and an average price target of $19.85.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 51,379 shares of the company’s stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03. Following the sale, the insider owned 362,333 shares in the company, valued at $6,366,190.81. This represents a 12.42% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph S. Konowiecki sold 4,832 shares of the stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $16.49, for a total value of $79,679.68. Following the completion of the sale, the director directly owned 1,081,141 shares in the company, valued at $17,828,015.09. This represents a 0.44% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 7,593,948 shares of company stock valued at $122,396,905. Insiders own 7.00% of the company’s stock.

Alignment Healthcare Stock Up 1.0%

Shares of NASDAQ:ALHC opened at $16.77 on Friday. The firm has a market capitalization of $3.36 billion, a PE ratio of -139.75 and a beta of 1.17. Alignment Healthcare, Inc. has a 1 year low of $10.18 and a 1 year high of $21.06. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The firm’s 50-day moving average is $16.97 and its two-hundred day moving average is $15.43.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The firm had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. During the same quarter in the previous year, the business posted ($0.14) earnings per share. The business’s quarterly revenue was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.